Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
21.55 USD | +0.14% | +0.37% | +124.25% |
Jun. 04 | Fusion Pharmaceuticals Says $2.4 Billion Acquisition by AstraZeneca Unit Is Complete | MT |
Jun. 04 | Fusion Pharmaceuticals Inc.(NasdaqGS:FUSN) dropped from NASDAQ Biotechnology Index | CI |
Financials (USD)
Sales 2024 * | 2.58M | Sales 2025 * | 1.27M | Capitalization | 1.83B |
---|---|---|---|---|---|
Net income 2024 * | -111M | Net income 2025 * | -136M | EV / Sales 2024 * | 671 x |
Net cash position 2024 * | 101M | Net cash position 2025 * | 170M | EV / Sales 2025 * | 1,310 x |
P/E ratio 2024 * |
-16.6
x | P/E ratio 2025 * |
-14.2
x | Employees | 101 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 0% |
Latest transcript on FUSN PHAR
1 day | +0.14% | ||
1 week | +0.37% | ||
Current month | +0.14% | ||
1 month | +0.61% | ||
3 months | +117.68% | ||
6 months | +299.07% | ||
Current year | +124.25% |
Managers | Title | Age | Since |
---|---|---|---|
Eric Burak
CTO | Chief Tech/Sci/R&D Officer | - | 17-01-31 |
Dmitri Bobilev
CTO | Chief Tech/Sci/R&D Officer | - | 22-11-06 |
Chief Tech/Sci/R&D Officer | 57 | 21-11-01 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.06% | 4 M€ | -5.15% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-06-03 | 21.55 | +0.14% | 6,089,181 |
24-05-31 | 21.52 | +0.23% | 952,407 |
24-05-30 | 21.47 | +0.28% | 3,961,572 |
24-05-29 | 21.41 | -0.19% | 1,390,044 |
Delayed Quote Nasdaq, June 03, 2024 at 04:00 pm EDT
More quotes- Stock Market
- Equities
- FUSN Stock